25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

Abbott Laboratories
Buy, Hold or Sell?

Let's analyze Abbott Laboratories together

I guess you are interested in Abbott Laboratories. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Abbott Laboratories. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Abbott Laboratories

I send you an email if I find something interesting about Abbott Laboratories.

1. Quick Overview

1.1. Quick analysis of Abbott Laboratories (30 sec.)










1.2. What can you expect buying and holding a share of Abbott Laboratories? (30 sec.)

How much money do you get?

How much money do you get?
€2.21
When do you have the money?
1 year
How often do you get paid?
100.0%

What is your share worth?

Current worth
€25.48
Expected worth in 1 year
€30.34
How sure are you?
95.2%

+ What do you gain per year?

Total Gains per Share
€6.89
Return On Investment
5.9%

For what price can you sell your share?

Current Price per Share
€116.18
Expected price per share
€108.19 - €134.10
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Abbott Laboratories (5 min.)




Live pricePrice per Share (EOD)
€116.18
Intrinsic Value Per Share
€19.08 - €21.49
Total Value Per Share
€44.56 - €46.97

2.2. Growth of Abbott Laboratories (5 min.)




Is Abbott Laboratories growing?

Current yearPrevious yearGrowGrow %
How rich?$47.8b$37.7b$3.8b9.2%

How much money is Abbott Laboratories making?

Current yearPrevious yearGrowGrow %
Making money$3.3b$1.4b$1.9b57.3%
Net Profit Margin31.1%14.3%--

How much money comes from the company's main activities?

2.3. Financial Health of Abbott Laboratories (5 min.)




2.4. Comparing to competitors in the Other industry (5 min.)




  Industry Rankings (Other)  

3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Abbott Laboratories?

Welcome investor! Abbott Laboratories's management wants to use your money to grow the business. In return you get a share of Abbott Laboratories.

First you should know what it really means to hold a share of Abbott Laboratories. And how you can make/lose money.

Speculation

The Price per Share of Abbott Laboratories is €116.18. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Abbott Laboratories.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Abbott Laboratories, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is €25.48. Based on the TTM, the Book Value Change Per Share is €1.21 per quarter. Based on the YOY, the Book Value Change Per Share is €0.27 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is €0.51 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Abbott Laboratories.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 % of Price per Share% of Price per Share% of Price per Share% of Price per Share% of Price per Share
Usd Eps5.334.6%1.931.7%0.820.7%1.080.9%0.920.8%
Usd Book Value Change Per Share4.583.9%1.321.1%0.290.2%0.500.4%1.321.1%
Usd Dividend Per Share0.550.5%0.550.5%0.510.4%0.470.4%0.460.4%
Usd Total Gains Per Share5.144.4%1.871.6%0.800.7%0.970.8%1.781.5%
Usd Price Per Share119.25-112.52-104.17-107.28-92.95-
Price to Earnings Ratio5.59-27.68-31.72-33.67-29.55-
Price-to-Total Gains Ratio23.22-115.39-137.87-161.87-154.39-
Price to Book Ratio4.31-4.71-4.79-5.19-4.53-
Price-to-Total Gains Ratio23.22-115.39-137.87-161.87-154.39-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share126.11339
Number of shares7
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.550.47
Usd Book Value Change Per Share1.320.50
Usd Total Gains Per Share1.870.97
Gains per Quarter (7 shares)13.096.76
Gains per Year (7 shares)52.3627.03
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
1153742131417
2317494262844
346111146404271
462148198535598
5771842506669125
6932213027983152
71082583549297179
8124295406105111206
9139332458119125233
10155369510132139260

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share4.00.00.0100.0%12.00.00.0100.0%20.00.00.0100.0%21.00.00.0100.0%21.00.00.0100.0%
Book Value Change Per Share4.00.00.0100.0%10.02.00.083.3%17.03.00.085.0%18.03.00.085.7%18.03.00.085.7%
Dividend per Share4.00.00.0100.0%12.00.00.0100.0%20.00.00.0100.0%21.00.00.0100.0%21.00.00.0100.0%
Total Gains per Share4.00.00.0100.0%12.00.00.0100.0%19.01.00.095.0%20.01.00.095.2%20.01.00.095.2%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of Abbott Laboratories compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--4.2221.214+248%0.266+1489%0.456+826%1.213+248%
Book Value Per Share--25.48222.090+15%20.052+27%19.133+33%16.626+53%
Current Ratio--1.6711.636+2%1.6730%1.711-2%1.686-1%
Debt To Asset Ratio--0.4120.448-8%0.483-15%0.503-18%0.509-19%
Debt To Equity Ratio--0.7030.819-14%0.941-25%1.030-32%1.053-33%
Dividend Per Share--0.5100.509+0%0.472+8%0.433+18%0.427+19%
Enterprise Value--159372165691.260148960837547.400+7%134065737314.830+19%139273144618.357+14%137622071379.011+16%
Eps--4.9091.780+176%0.759+547%0.992+395%0.849+478%
Ev To Ebitda Ratio--infinfnan%infnan%infnan%infnan%
Ev To Sales Ratio--3.9413.857+2%3.628+9%3.717+6%3.703+6%
Free Cash Flow Per Share--1.1430.843+36%0.671+70%0.883+29%0.883+29%
Free Cash Flow To Equity Per Share--0.1530.126+21%-0.269+276%0.134+14%0.134+14%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max--21.493--------
Intrinsic Value_10Y_min--19.076--------
Intrinsic Value_1Y_max--3.217--------
Intrinsic Value_1Y_min--3.160--------
Intrinsic Value_3Y_max--8.855--------
Intrinsic Value_3Y_min--8.470--------
Intrinsic Value_5Y_max--13.517--------
Intrinsic Value_5Y_min--12.616--------
Market Cap--190244341291.260179987314147.400+6%166605975814.830+14%173091225698.357+10%150005339323.301+27%
Net Profit Margin--0.8410.311+170%0.143+490%0.179+370%0.168+399%
Operating Margin----0%-0%0.050-100%0.082-100%
Operating Ratio--1.2761.284-1%1.287-1%1.269+1%1.270+0%
Pb Ratio4.559+5%4.3114.714-9%4.786-10%5.192-17%4.527-5%
Pe Ratio5.916+5%5.59427.679-80%31.724-82%33.672-83%29.551-81%
Price Per Share116.180+5%109.860103.660+6%95.968+14%98.826+11%85.625+28%
Price To Free Cash Flow Ratio25.419+5%24.03639.460-39%44.508-46%36.556-34%30.464-21%
Price To Total Gains Ratio24.554+5%23.218115.393-80%137.872-83%161.873-86%154.389-85%
Quick Ratio--0.5140.504+2%0.480+7%0.5150%0.526-2%
Return On Assets--0.1130.043+166%0.020+479%0.025+352%0.023+389%
Return On Equity--0.1940.075+158%0.038+409%0.050+291%0.046+319%
Total Gains Per Share--4.7321.723+175%0.737+542%0.889+432%1.640+188%
Usd Book Value--47899208502.60041631442925.800+15%37787836682.050+27%36354890276.250+32%35559836679.033+35%
Usd Book Value Change Per Share--4.5831.318+248%0.288+1489%0.495+826%1.317+248%
Usd Book Value Per Share--27.66023.979+15%21.766+27%20.769+33%18.047+53%
Usd Dividend Per Share--0.5530.552+0%0.512+8%0.470+18%0.463+19%
Usd Enterprise Value--172998485857.863161696989157.703+7%145528357855.248+19%151180998483.226+14%149388758481.916+16%
Usd Eps--5.3291.933+176%0.824+547%1.076+395%0.922+478%
Usd Free Cash Flow--2147919664.8001587690618.150+35%1264702698.350+70%1679237194.180+28%1399364328.483+53%
Usd Free Cash Flow Per Share--1.2400.915+36%0.729+70%0.958+29%0.958+29%
Usd Free Cash Flow To Equity Per Share--0.1660.137+21%-0.292+276%0.146+14%0.146+14%
Usd Market Cap--206510232471.663195376229507.003+6%180850786746.998+14%187890525495.566+10%162830795835.443+27%
Usd Price Per Share126.113+5%119.253112.523+6%104.173+14%107.276+11%92.945+28%
Usd Profit--9228654835.4003350374691.300+175%1430696489.950+545%1881129643.120+391%1721227290.358+436%
Usd Revenue--10973589572.40010487107767.500+5%10026874980.850+9%10169369651.350+8%9803758325.725+12%
Usd Total Gains Per Share--5.1361.870+175%0.801+542%0.965+432%1.780+188%
 EOD+2 -4MRQTTM+35 -2YOY+34 -35Y+32 -610Y+32 -6

3.3 Fundamental Score

Let's check the fundamental score of Abbott Laboratories based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-155.916
Price to Book Ratio (EOD)Between0-14.559
Net Profit Margin (MRQ)Greater than00.841
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.514
Current Ratio (MRQ)Greater than11.671
Debt to Asset Ratio (MRQ)Less than10.412
Debt to Equity Ratio (MRQ)Less than10.703
Return on Equity (MRQ)Greater than0.150.194
Return on Assets (MRQ)Greater than0.050.113
Total7/10 (70.0%)

3.4 Technical Score

Let's check the technical score of Abbott Laboratories based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
OpenGreater thanClose117.660
Total1/1 (100.0%)

4. In-depth Analysis

4.1 About Abbott Laboratories

  • Other
  • 0

There is no Profile data available for ABL.SG.

Fundamental data was last updated by Penke on 2025-03-05 20:26:02.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge profit.
Using its assets, the company is less efficient in making profit.
Using its investors money, the company is less efficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is fair priced.
Based on the earnings, the company is overpriced.
Based on how much money comes from the company's main activities, the company is fair priced.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profit Abbott Laboratories earns for each €1 of revenue.

  • Above 10% is considered healthy but always compare Abbott Laboratories to the Other industry mean.
  • A Net Profit Margin of 84.1% means that €0.84 for each €1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Abbott Laboratories:

  • The MRQ is 84.1%. The company is making a huge profit. +2
  • The TTM is 31.1%. The company is making a huge profit. +2
Trends
Current periodCompared to+/- 
MRQ84.1%TTM31.1%+53.0%
TTM31.1%YOY14.3%+16.8%
TTM31.1%5Y17.9%+13.2%
5Y17.9%10Y16.8%+1.1%
Compared to industry (Other)
PeriodCompanyIndustry (mean)+/- 
MRQ84.1%5.6%+78.5%
TTM31.1%5.9%+25.2%
YOY14.3%6.1%+8.2%
5Y17.9%6.2%+11.7%
10Y16.8%6.1%+10.7%
4.3.1.2. Return on Assets

Shows how efficient Abbott Laboratories is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Abbott Laboratories to the Other industry mean.
  • 11.3% Return on Assets means that Abbott Laboratories generated €0.11 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Abbott Laboratories:

  • The MRQ is 11.3%. Using its assets, the company is efficient in making profit. +1
  • The TTM is 4.3%. Using its assets, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ11.3%TTM4.3%+7.1%
TTM4.3%YOY2.0%+2.3%
TTM4.3%5Y2.5%+1.7%
5Y2.5%10Y2.3%+0.2%
Compared to industry (Other)
PeriodCompanyIndustry (mean)+/- 
MRQ11.3%1.3%+10.0%
TTM4.3%1.1%+3.2%
YOY2.0%1.3%+0.7%
5Y2.5%1.3%+1.2%
10Y2.3%1.3%+1.0%
4.3.1.3. Return on Equity

Shows how efficient Abbott Laboratories is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Abbott Laboratories to the Other industry mean.
  • 19.4% Return on Equity means Abbott Laboratories generated €0.19 for each €1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Abbott Laboratories:

  • The MRQ is 19.4%. Using its investors money, the company is efficient in making profit. +1
  • The TTM is 7.5%. Using its investors money, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ19.4%TTM7.5%+11.9%
TTM7.5%YOY3.8%+3.7%
TTM7.5%5Y5.0%+2.5%
5Y5.0%10Y4.6%+0.3%
Compared to industry (Other)
PeriodCompanyIndustry (mean)+/- 
MRQ19.4%3.7%+15.7%
TTM7.5%3.4%+4.1%
YOY3.8%3.9%-0.1%
5Y5.0%3.9%+1.1%
10Y4.6%3.8%+0.8%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of Abbott Laboratories.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

Measures how efficient Abbott Laboratories is operating .

  • Measures how much profit Abbott Laboratories makes for each €1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Abbott Laboratories to the Other industry mean.
  • An Operating Margin of 0.0% means the company generated €0.00  for each €1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Abbott Laboratories:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y5.0%-5.0%
5Y5.0%10Y8.2%-3.2%
Compared to industry (Other)
PeriodCompanyIndustry (mean)+/- 
MRQ-12.7%-12.7%
TTM-8.2%-8.2%
YOY-7.8%-7.8%
5Y5.0%4.4%+0.6%
10Y8.2%6.8%+1.4%
4.3.2.2. Operating Ratio

Measures how efficient Abbott Laboratories is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Other industry mean).
  • An Operation Ratio of 1.28 means that the operating costs are €1.28 for each €1 in net sales.

Let's take a look of the Operating Ratio trends of Abbott Laboratories:

  • The MRQ is 1.276. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.284. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.276TTM1.284-0.007
TTM1.284YOY1.287-0.003
TTM1.2845Y1.269+0.015
5Y1.26910Y1.270-0.001
Compared to industry (Other)
PeriodCompanyIndustry (mean)+/- 
MRQ1.2761.313-0.037
TTM1.2841.355-0.071
YOY1.2871.375-0.088
5Y1.2691.324-0.055
10Y1.2701.381-0.111
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of Abbott Laboratories.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Abbott Laboratories is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Other industry mean).
  • A Current Ratio of 1.67 means the company has €1.67 in assets for each €1 in short-term debts.

Let's take a look of the Current Ratio trends of Abbott Laboratories:

  • The MRQ is 1.671. The company is able to pay all its short-term debts. +1
  • The TTM is 1.636. The company is able to pay all its short-term debts. +1
Trends
Current periodCompared to+/- 
MRQ1.671TTM1.636+0.035
TTM1.636YOY1.673-0.037
TTM1.6365Y1.711-0.075
5Y1.71110Y1.686+0.025
Compared to industry (Other)
PeriodCompanyIndustry (mean)+/- 
MRQ1.6711.426+0.245
TTM1.6361.416+0.220
YOY1.6731.538+0.135
5Y1.7111.562+0.149
10Y1.6861.496+0.190
4.4.3.2. Quick Ratio

Measures if Abbott Laboratories is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Abbott Laboratories to the Other industry mean.
  • A Quick Ratio of 0.51 means the company can pay off €0.51 for each €1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Abbott Laboratories:

  • The MRQ is 0.514. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.504. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.514TTM0.504+0.010
TTM0.504YOY0.480+0.024
TTM0.5045Y0.515-0.011
5Y0.51510Y0.526-0.011
Compared to industry (Other)
PeriodCompanyIndustry (mean)+/- 
MRQ0.5140.531-0.017
TTM0.5040.553-0.049
YOY0.4800.603-0.123
5Y0.5150.606-0.091
10Y0.5260.609-0.083
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of Abbott Laboratories.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much % of Abbott Laboratories assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Abbott Laboratories to Other industry mean.
  • A Debt to Asset Ratio of 0.41 means that Abbott Laboratories assets are financed with 41.2% credit (debt) and the remaining percentage (100% - 41.2%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Abbott Laboratories:

  • The MRQ is 0.412. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.448. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.412TTM0.448-0.037
TTM0.448YOY0.483-0.035
TTM0.4485Y0.503-0.055
5Y0.50310Y0.509-0.005
Compared to industry (Other)
PeriodCompanyIndustry (mean)+/- 
MRQ0.4120.520-0.108
TTM0.4480.529-0.081
YOY0.4830.523-0.040
5Y0.5030.555-0.052
10Y0.5090.564-0.055
4.5.4.2. Debt to Equity Ratio

Measures if Abbott Laboratories is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Abbott Laboratories to the Other industry mean.
  • A Debt to Equity ratio of 70.3% means that company has €0.70 debt for each €1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Abbott Laboratories:

  • The MRQ is 0.703. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.819. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.703TTM0.819-0.116
TTM0.819YOY0.941-0.121
TTM0.8195Y1.030-0.211
5Y1.03010Y1.053-0.022
Compared to industry (Other)
PeriodCompanyIndustry (mean)+/- 
MRQ0.7031.095-0.392
TTM0.8191.128-0.309
YOY0.9411.155-0.214
5Y1.0301.338-0.308
10Y1.0531.429-0.376
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every €1 in earnings Abbott Laboratories generates.

  • Above 15 is considered overpriced but always compare Abbott Laboratories to the Other industry mean.
  • A PE ratio of 5.59 means the investor is paying €5.59 for every €1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Abbott Laboratories:

  • The EOD is 5.916. Based on the earnings, the company is cheap. +2
  • The MRQ is 5.594. Based on the earnings, the company is cheap. +2
  • The TTM is 27.679. Based on the earnings, the company is overpriced. -1
Trends
Current periodCompared to+/- 
EOD5.916MRQ5.594+0.322
MRQ5.594TTM27.679-22.085
TTM27.679YOY31.724-4.045
TTM27.6795Y33.672-5.993
5Y33.67210Y29.551+4.121
Compared to industry (Other)
PeriodCompanyIndustry (mean)+/- 
EOD5.91614.089-8.173
MRQ5.59413.537-7.943
TTM27.67912.493+15.186
YOY31.72411.191+20.533
5Y33.67212.976+20.696
10Y29.55113.175+16.376
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Abbott Laboratories:

  • The EOD is 25.419. Based on how much money comes from the company's main activities, the company is underpriced. +1
  • The MRQ is 24.036. Based on how much money comes from the company's main activities, the company is underpriced. +1
  • The TTM is 39.460. Based on how much money comes from the company's main activities, the company is fair priced.
Trends
Current periodCompared to+/- 
EOD25.419MRQ24.036+1.383
MRQ24.036TTM39.460-15.423
TTM39.460YOY44.508-5.049
TTM39.4605Y36.556+2.903
5Y36.55610Y30.464+6.093
Compared to industry (Other)
PeriodCompanyIndustry (mean)+/- 
EOD25.4198.643+16.776
MRQ24.0368.169+15.867
TTM39.4607.139+32.321
YOY44.5085.896+38.612
5Y36.5563.220+33.336
10Y30.4643.714+26.750
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price of Abbott Laboratories is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Other industry mean).
  • A PB ratio of 4.31 means the investor is paying €4.31 for each €1 in book value.

Let's take a look of the Price to Book Ratio trends of Abbott Laboratories:

  • The EOD is 4.559. Based on the equity, the company is fair priced.
  • The MRQ is 4.311. Based on the equity, the company is fair priced.
  • The TTM is 4.714. Based on the equity, the company is fair priced.
Trends
Current periodCompared to+/- 
EOD4.559MRQ4.311+0.248
MRQ4.311TTM4.714-0.403
TTM4.714YOY4.786-0.072
TTM4.7145Y5.192-0.478
5Y5.19210Y4.527+0.666
Compared to industry (Other)
PeriodCompanyIndustry (mean)+/- 
EOD4.5591.532+3.027
MRQ4.3111.404+2.907
TTM4.7141.428+3.286
YOY4.7861.405+3.381
5Y5.1921.718+3.474
10Y4.5271.715+2.812
4.6.2. Total Gains per Share

2.4. Latest News of Abbott Laboratories

Does Abbott Laboratories still have the same value as the quarterly reports suggest? Recent changes may be an indication that the value of the company is changing. Read the news from Abbott Laboratories to keep up to date. Note: the news is often already included in the price.

DateTitleRead
2025-03-13
22:50
Abbott (ABT) Stock Moves -0.3%: What You Should KnowRead
2025-03-11
14:00
Abbott Laboratories (ABT) is Attracting Investor Attention: Here is What You Should KnowRead
2025-03-08
12:00
Estimating The Fair Value Of Abbott Laboratories (NYSE:ABT)Read
2025-02-27
23:50
Abbott (ABT) Stock Moves -0.07%: What You Should KnowRead
2025-02-22
13:00
Abbott Laboratories' (NYSE:ABT) five-year earnings growth trails the 14% YoY shareholder returnsRead
2025-02-21
23:50
Abbott (ABT) Gains As Market Dips: What You Should KnowRead
2025-02-21
16:48
Abbott Declares 405th Consecutive Quarterly DividendRead
2025-02-21
15:35
Showing Students the World of Possibilities in STEMRead
2025-02-21
00:00
Abbott (ABT) Increases Despite Market Slip: Here's What You Need to KnowRead
2025-02-17
08:47
Abbott Laboratories (ABT): Among the Best Drug Stocks to Buy NowRead
3rd party ad coffee SUPPORTERis ad-free.

6. Financial Statements




6.1. Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2023-12-312024-03-312024-06-302024-09-302024-12-31
Tax Provision  185,1619,212194,37386,593280,966-10,133270,833-6,902,552-6,631,719



6.2. Latest Balance Sheet

Balance Sheet of 2024-12-31. Currency in USD. All numbers in thousands.

Summary
Total Assets81,414,000
Total Liabilities33,513,000
Total Stockholder Equity47,664,000
 As reported
Total Liabilities 33,513,000
Total Stockholder Equity+ 47,664,000
Total Assets = 81,414,000

Assets

Total Assets81,414,000
Total Current Assets23,656,000
Long-term Assets57,758,000
Total Current Assets
Cash And Cash Equivalents 7,616,000
Short-term Investments 351,000
Net Receivables 6,925,000
Inventory 6,194,000
Total Current Assets  (as reported)23,656,000
Total Current Assets  (calculated)21,086,000
+/- 2,570,000
Long-term Assets
Property Plant Equipment 10,658,000
Goodwill 23,108,000
Long Term Investments 886,000
Intangible Assets 6,647,000
Long-term Assets Other 16,459,000
Long-term Assets  (as reported)57,758,000
Long-term Assets  (calculated)57,758,000
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities14,157,000
Long-term Liabilities19,356,000
Total Stockholder Equity47,664,000
Total Current Liabilities
Short Long Term Debt 1,500,000
Accounts payable 4,195,000
Total Current Liabilities  (as reported)14,157,000
Total Current Liabilities  (calculated)5,695,000
+/- 8,462,000
Long-term Liabilities
Long term Debt 12,625,000
Capital Lease Obligations Min Short Term Debt896,000
Long-term Liabilities Other 3,443,000
Long-term Liabilities  (as reported)19,356,000
Long-term Liabilities  (calculated)16,964,000
+/- 2,392,000
Total Stockholder Equity
Retained Earnings 47,261,000
Total Stockholder Equity (as reported)47,664,000
Total Stockholder Equity (calculated)47,261,000
+/- 403,000
Other
Capital Stock25,153,000
Common Stock Shares Outstanding 1,731,698
Net Debt 6,509,000
Net Invested Capital 61,789,000
Net Working Capital 9,499,000
Property Plant and Equipment Gross 22,740,000



6.3. Balance Sheets Structured

Currency in USD. All numbers in thousands.

 Trend2024-12-312024-09-302024-06-302024-03-312023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-31
> Total Assets 
67,610,000
68,427,000
68,539,000
67,887,000
66,777,000
68,776,000
69,043,000
72,548,000
72,785,000
73,269,000
73,795,000
75,196,000
74,007,000
74,202,000
72,801,000
74,438,000
73,794,000
73,354,000
72,090,000
73,214,000
72,467,000
73,017,000
74,356,000
81,414,000
81,414,00074,356,00073,017,00072,467,00073,214,00072,090,00073,354,00073,794,00074,438,00072,801,00074,202,00074,007,00075,196,00073,795,00073,269,00072,785,00072,548,00069,043,00068,776,00066,777,00067,887,00068,539,00068,427,00067,610,000
   > Total Current Assets 
14,409,000
15,195,000
16,119,000
15,667,000
15,498,000
17,221,000
17,390,000
20,441,000
21,817,000
22,627,000
23,492,000
24,239,000
23,429,000
24,956,000
24,845,000
25,224,000
24,377,000
23,505,000
22,664,000
22,670,000
22,376,000
23,119,000
23,802,000
23,656,000
23,656,00023,802,00023,119,00022,376,00022,670,00022,664,00023,505,00024,377,00025,224,00024,845,00024,956,00023,429,00024,239,00023,492,00022,627,00021,817,00020,441,00017,390,00017,221,00015,498,00015,667,00016,119,00015,195,00014,409,000
       Cash And Cash Equivalents 
3,022,000
3,137,000
4,091,000
3,860,000
3,377,000
4,763,000
4,480,000
6,838,000
8,054,000
8,658,000
9,302,000
9,799,000
7,675,000
8,937,000
9,594,000
9,882,000
9,161,000
7,835,000
6,709,000
6,896,000
6,284,000
6,987,000
7,558,000
7,616,000
7,616,0007,558,0006,987,0006,284,0006,896,0006,709,0007,835,0009,161,0009,882,0009,594,0008,937,0007,675,0009,799,0009,302,0008,658,0008,054,0006,838,0004,480,0004,763,0003,377,0003,860,0004,091,0003,137,0003,022,000
       Short-term Investments 
239,000
239,000
244,000
280,000
291,000
274,000
251,000
310,000
318,000
286,000
390,000
450,000
483,000
353,000
313,000
288,000
371,000
320,000
338,000
383,000
367,000
232,000
230,000
351,000
351,000230,000232,000367,000383,000338,000320,000371,000288,000313,000353,000483,000450,000390,000286,000318,000310,000251,000274,000291,000280,000244,000239,000239,000
       Net Receivables 
5,345,000
5,548,000
5,450,000
5,425,000
5,292,000
5,140,000
5,649,000
6,414,000
6,096,000
6,113,000
6,405,000
6,487,000
7,179,000
7,199,000
6,408,000
6,218,000
6,020,000
6,172,000
6,499,000
6,565,000
6,605,000
6,854,000
7,051,000
6,925,000
6,925,0007,051,0006,854,0006,605,0006,565,0006,499,0006,172,0006,020,0006,218,0006,408,0007,199,0007,179,0006,487,0006,405,0006,113,0006,096,0006,414,0005,649,0005,140,0005,292,0005,425,0005,450,0005,548,0005,345,000
       Inventory 
4,085,000
4,352,000
4,392,000
4,316,000
4,568,000
5,202,000
5,152,000
5,012,000
5,387,000
5,439,000
5,261,000
5,157,000
5,691,000
5,899,000
5,734,000
6,173,000
6,673,000
6,871,000
6,650,000
6,570,000
6,827,000
6,814,000
6,813,000
6,194,000
6,194,0006,813,0006,814,0006,827,0006,570,0006,650,0006,871,0006,673,0006,173,0005,734,0005,899,0005,691,0005,157,0005,261,0005,439,0005,387,0005,012,0005,152,0005,202,0004,568,0004,316,0004,392,0004,352,0004,085,000
   > Long-term Assets 
53,201,000
53,232,000
52,455,000
52,220,000
51,214,000
51,572,000
51,653,000
52,107,000
50,968,000
50,642,000
50,303,000
50,957,000
50,578,000
49,246,000
47,956,000
49,214,000
49,417,000
49,849,000
49,426,000
50,544,000
50,091,000
49,898,000
50,554,000
57,758,000
57,758,00050,554,00049,898,00050,091,00050,544,00049,426,00049,849,00049,417,00049,214,00047,956,00049,246,00050,578,00050,957,00050,303,00050,642,00050,968,00052,107,00051,653,00051,572,00051,214,00052,220,00052,455,00053,232,00053,201,000
       Property Plant Equipment 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
8,689,000
9,162,000
9,282,000
9,449,000
9,552,000
10,154,000
10,107,000
10,233,000
10,621,000
10,658,000
10,658,00010,621,00010,233,00010,107,00010,154,0009,552,0009,449,0009,282,0009,162,0008,689,00000000000000000
       Goodwill 
23,209,000
23,329,000
23,046,000
23,195,000
22,927,000
23,082,000
23,338,000
23,744,000
23,384,000
23,485,000
23,299,000
23,231,000
23,179,000
22,744,000
22,284,000
22,799,000
22,927,000
23,258,000
23,277,000
23,679,000
23,383,000
23,308,000
23,658,000
23,108,000
23,108,00023,658,00023,308,00023,383,00023,679,00023,277,00023,258,00022,927,00022,799,00022,284,00022,744,00023,179,00023,231,00023,299,00023,485,00023,384,00023,744,00023,338,00023,082,00022,927,00023,195,00023,046,00023,329,00023,209,000
       Long Term Investments 
867,000
851,000
874,000
883,000
790,000
776,000
803,000
821,000
832,000
805,000
812,000
816,000
763,000
734,000
764,000
766,000
776,000
799,000
788,000
799,000
818,000
877,000
912,000
886,000
886,000912,000877,000818,000799,000788,000799,000776,000766,000764,000734,000763,000816,000812,000805,000832,000821,000803,000776,000790,000883,000874,000851,000867,000
       Intangible Assets 
18,472,000
18,091,000
17,500,000
17,025,000
16,200,000
15,800,000
15,208,000
14,784,000
14,181,000
13,681,000
13,312,000
12,739,000
12,225,000
11,592,000
10,850,000
10,454,000
10,006,000
9,834,000
9,282,000
8,815,000
8,296,000
7,827,000
7,352,000
6,647,000
6,647,0007,352,0007,827,0008,296,0008,815,0009,282,0009,834,00010,006,00010,454,00010,850,00011,592,00012,225,00012,739,00013,312,00013,681,00014,181,00014,784,00015,208,00015,800,00016,200,00017,025,00017,500,00018,091,00018,472,000
> Total Liabilities 
36,481,000
36,533,000
36,520,000
36,586,000
36,350,000
37,978,000
37,448,000
39,545,000
38,997,000
39,240,000
39,157,000
39,172,000
38,378,000
37,486,000
36,917,000
37,533,000
36,562,000
35,950,000
34,396,000
34,387,000
33,424,000
33,457,000
34,328,000
33,513,000
33,513,00034,328,00033,457,00033,424,00034,387,00034,396,00035,950,00036,562,00037,533,00036,917,00037,486,00038,378,00039,172,00039,157,00039,240,00038,997,00039,545,00037,448,00037,978,00036,350,00036,586,00036,520,00036,533,00036,481,000
   > Total Current Liabilities 
9,113,000
9,062,000
10,491,000
10,863,000
10,808,000
10,959,000
10,257,000
11,907,000
12,462,000
12,614,000
12,867,000
13,105,000
12,647,000
12,392,000
13,365,000
15,489,000
14,530,000
14,350,000
13,042,000
13,841,000
14,021,000
13,760,000
14,902,000
14,157,000
14,157,00014,902,00013,760,00014,021,00013,841,00013,042,00014,350,00014,530,00015,489,00013,365,00012,392,00012,647,00013,105,00012,867,00012,614,00012,462,00011,907,00010,257,00010,959,00010,808,00010,863,00010,491,0009,062,0009,113,000
       Short-term Debt 
209,000
212,000
1,458,000
1,478,000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000000001,478,0001,458,000212,000209,000
       Short Long Term Debt 
209,000
212,000
1,458,000
1,478,000
1,468,000
1,495,000
214,000
220,000
955,000
954,000
951,000
754,000
4,000
5,000
1,117,000
2,251,000
2,285,000
2,284,000
1,051,000
1,080,000
2,010,000
1,615,000
2,154,000
1,500,000
1,500,0002,154,0001,615,0002,010,0001,080,0001,051,0002,284,0002,285,0002,251,0001,117,0005,0004,000754,000951,000954,000955,000220,000214,0001,495,0001,468,0001,478,0001,458,000212,000209,000
       Accounts payable 
3,045,000
3,222,000
3,029,000
3,252,000
3,181,000
3,335,000
3,189,000
3,946,000
4,066,000
4,017,000
4,017,000
4,408,000
4,757,000
4,493,000
4,133,000
4,607,000
4,167,000
4,211,000
3,961,000
4,295,000
4,178,000
4,125,000
4,034,000
4,195,000
4,195,0004,034,0004,125,0004,178,0004,295,0003,961,0004,211,0004,167,0004,607,0004,133,0004,493,0004,757,0004,408,0004,017,0004,017,0004,066,0003,946,0003,189,0003,335,0003,181,0003,252,0003,029,0003,222,0003,045,000
   > Long-term Liabilities 
27,368,000
27,471,000
26,029,000
25,723,000
25,542,000
27,019,000
27,191,000
27,638,000
26,535,000
26,626,000
26,290,000
26,067,000
25,731,000
25,094,000
23,552,000
22,044,000
22,032,000
21,600,000
21,354,000
20,546,000
19,403,000
19,697,000
19,426,000
19,356,000
19,356,00019,426,00019,697,00019,403,00020,546,00021,354,00021,600,00022,032,00022,044,00023,552,00025,094,00025,731,00026,067,00026,290,00026,626,00026,535,00027,638,00027,191,00027,019,00025,542,00025,723,00026,029,00027,471,00027,368,000
       Long term Debt 
18,845,000
18,982,000
17,639,000
16,661,000
16,804,000
18,184,000
18,349,000
18,527,000
17,489,000
17,547,000
17,446,000
17,296,000
17,086,000
16,755,000
15,297,000
14,522,000
14,615,000
14,562,000
14,477,000
13,599,000
12,576,000
13,139,000
12,825,000
12,625,000
12,625,00012,825,00013,139,00012,576,00013,599,00014,477,00014,562,00014,615,00014,522,00015,297,00016,755,00017,086,00017,296,00017,446,00017,547,00017,489,00018,527,00018,349,00018,184,00016,804,00016,661,00017,639,00018,982,00018,845,000
       Capital Lease Obligations 
0
0
0
755,000
0
0
0
902,000
0
0
0
956,000
0
0
0
943,000
0
0
0
949,000
0
0
0
896,000
896,000000949,000000943,000000956,000000902,000000755,000000
       Long-term Liabilities Other 
0
0
0
3,944,000
0
0
0
3,684,000
0
0
0
3,685,000
0
8,339,000
8,255,000
3,804,000
7,417,000
7,038,000
6,877,000
3,466,000
6,827,000
6,558,000
6,601,000
3,443,000
3,443,0006,601,0006,558,0006,827,0003,466,0006,877,0007,038,0007,417,0003,804,0008,255,0008,339,00003,685,0000003,684,0000003,944,000000
> Total Stockholder Equity
30,925,000
31,686,000
31,817,000
31,088,000
30,218,000
30,578,000
31,386,000
32,784,000
33,562,000
33,800,000
34,422,000
35,802,000
35,399,000
36,490,000
35,675,000
36,686,000
37,010,000
37,174,000
37,481,000
38,603,000
38,810,000
39,318,000
39,796,000
47,664,000
47,664,00039,796,00039,318,00038,810,00038,603,00037,481,00037,174,00037,010,00036,686,00035,675,00036,490,00035,399,00035,802,00034,422,00033,800,00033,562,00032,784,00031,386,00030,578,00030,218,00031,088,00031,817,00031,686,00030,925,000
   Common Stock000000000000000000000000
   Retained Earnings 
24,613,000
25,045,000
25,440,000
25,847,000
25,786,000
25,669,000
26,266,000
27,627,000
28,669,000
29,053,000
30,376,000
31,528,000
33,295,000
34,487,000
35,115,000
35,257,000
35,868,000
36,355,000
36,920,000
37,554,000
38,011,000
38,354,000
39,056,000
47,261,000
47,261,00039,056,00038,354,00038,011,00037,554,00036,920,00036,355,00035,868,00035,257,00035,115,00034,487,00033,295,00031,528,00030,376,00029,053,00028,669,00027,627,00026,266,00025,669,00025,786,00025,847,00025,440,00025,045,00024,613,000
   Capital Surplus 000000000000000000000000
   Treasury Stock000000000000000000000000
   Other Stockholders Equity 000000000000000000000000



6.4. Balance Sheets

Currency in USD. All numbers in thousands.




6.5. Cash Flows

Currency in USD. All numbers in thousands.




6.6. Income Statements

Currency in USD. All numbers in thousands.


6.7. Latest Income Statement

Income Statement (annual), 2024-12-31. Currency in USD. All numbers in thousands.

Gross Profit (+$)
totalRevenue41,950,000
Cost of Revenue-18,706,000
Gross Profit23,244,00023,244,000
 
Operating Income (+$)
Gross Profit23,244,000
Operating Expense-35,125,000
Operating Income6,825,000-11,881,000
 
Operating Expense (+$)
Research Development2,844,000
Selling General Administrative11,697,000
Selling And Marketing Expenses-
Operating Expense35,125,00014,541,000
 
Net Interest Income (+$)
Interest Income344,000
Interest Expense-559,000
Other Finance Cost-0
Net Interest Income-215,000
 
Pretax Income (+$)
Operating Income6,825,000
Net Interest Income-215,000
Other Non-Operating Income Expenses-
Income Before Tax (EBT)7,013,0006,422,000
EBIT - interestExpense = -559,000
13,402,000
13,961,000
Interest Expense559,000
Earnings Before Interest and Taxes (EBIT)-7,572,000
Earnings Before Interest and Taxes (EBITDA)-
 
After tax Income (+$)
Income Before Tax7,013,000
Tax Provision--6,389,000
Net Income From Continuing Ops13,402,00013,402,000
Net Income13,402,000
Net Income Applicable To Common Shares-
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses-
Total Other Income/Expenses Net403,000215,000
 

Technical Analysis of Abbott Laboratories
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Abbott Laboratories. The general trend of Abbott Laboratories is UNKNOWN with 0.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Abbott Laboratories's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator StateBullish trend Bearish trend
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Abbott Laboratories.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 123.02 < 134.10.

The bearish price targets are: 111.79 > 110.48 > 108.19.

Tweet this
Abbott Laboratories Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Abbott Laboratories. The current mas is .

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Abbott Laboratories Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Abbott Laboratories.

Abbott Laboratories Daily Moving Average Convergence/Divergence (MACD) ChartAbbott Laboratories Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Abbott Laboratories. The current adx is .

Abbott Laboratories Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Abbott Laboratories.

Abbott Laboratories Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Abbott Laboratories.

Abbott Laboratories Daily Relative Strength Index (RSI) ChartAbbott Laboratories Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Abbott Laboratories.

Abbott Laboratories Daily Stochastic Oscillator ChartAbbott Laboratories Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Abbott Laboratories.

Abbott Laboratories Daily Commodity Channel Index (CCI) ChartAbbott Laboratories Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Abbott Laboratories.

Abbott Laboratories Daily Chande Momentum Oscillator (CMO) ChartAbbott Laboratories Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Abbott Laboratories.

Abbott Laboratories Daily Williams %R ChartAbbott Laboratories Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Abbott Laboratories.

Abbott Laboratories Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Abbott Laboratories.

Abbott Laboratories Daily Average True Range (ATR) ChartAbbott Laboratories Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Abbott Laboratories.

Abbott Laboratories Daily On-Balance Volume (OBV) ChartAbbott Laboratories Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Abbott Laboratories.

Abbott Laboratories Daily Money Flow Index (MFI) ChartAbbott Laboratories Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Abbott Laboratories.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2024-10-22RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2024-10-23STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-24STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-25SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-10-28MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-10-29WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-10-30STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-31STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-11-01SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-11-04ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-11-05STOCH LONG EXITThe %K line crosses below the %D line.
2024-11-06MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-11-07MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-11-08STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-11-11MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-11-13STOCH LONG EXITThe %K line crosses below the %D line.
2024-11-15STOCH SHORT EXITThe %K line crosses above the %D line.
2024-11-18CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-11-19STOCH LONG EXITThe %K line crosses below the %D line.
2024-11-21STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-11-27STOCH LONG EXITThe %K line crosses below the %D line.
2024-11-29STOCH SHORT EXITThe %K line crosses above the %D line.
2024-12-02MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-12-03CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-12-05SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-12-09DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-12-10DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-12-11STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-12-12DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-12-13STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-12-16STOCH LONG EXITThe %K line crosses below the %D line.
2024-12-17STOCH SHORT EXITThe %K line crosses above the %D line.
2024-12-23DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-12-27SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-12-30MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-01-03STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-01-06STOCH LONG EXITThe %K line crosses below the %D line.
2025-01-08CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-01-09MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2025-01-10MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-01-14STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-01-15MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-01-16STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-01-17MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2025-01-20MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2025-01-21MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-01-22DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-01-23ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-01-27STOCH LONG EXITThe %K line crosses below the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-01-29STOCH SHORT EXITThe %K line crosses above the %D line.
2025-01-31STOCH LONG EXITThe %K line crosses below the %D line.
2025-02-03STOCH SHORT EXITThe %K line crosses above the %D line.
2025-02-04STOCH LONG EXITThe %K line crosses below the %D line.
2025-02-05STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-02-06RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-02-07WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-02-10STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-02-11RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2025-02-12STOCH LONG EXITThe %K line crosses below the %D line.
2025-02-13SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2025-02-14MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-02-17ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-02-19STOCH SHORT EXITThe %K line crosses above the %D line.
2025-02-21SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-02-25STOCH LONG EXITThe %K line crosses below the %D line.
2025-02-26STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-02-27BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2025-02-28RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2025-03-03MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-03-04MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-03-05CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-03-06SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-03-10STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2025-03-11DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-03-13STOCH SHORT EXITThe %K line crosses above the %D line.

6.3. Candlestick Patterns

Abbott Laboratories Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Abbott Laboratories based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
OpenGreater thanClose117.660
Total1/1 (100.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of Abbott Laboratories with someone you think should read this too:
  • Are you bullish or bearish on Abbott Laboratories? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Abbott Laboratories? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Abbott Laboratories

I send you an email if I find something interesting about Abbott Laboratories.


Comments

How you think about this?

Leave a comment

Stay informed about Abbott Laboratories.

Receive notifications about Abbott Laboratories in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.